Acute Kidney Injury Therapeutics Market

Acute kidney injury therapeutics is the cure to the acute kidney injury that is a group of clinical syndromes that refers to sudden (within 1-7d) and sustained (> 24h) sudden declines in renal function. It is defined as an increase in serum creatinine (SCr) of at least 0.5mg / dl 1 and manifested as nitrogen. Plasmaemia, water-electrolyte and acid-base balance and systemic symptoms can be accompanied by oliguria (<400ml / 24h or 17ml / h) or anuria (<100ml / 24h). Acute Kidney Injury Therapeutics Market contains market size and forecasts of Acute Kidney Injury Therapeutics in Global, including the following market information: Global Acute Kidney Injury Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions) Global top five companies in 2021 (%) The global Acute Kidney Injury Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period. The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028. Non-drug Segment to Reach $ Million by 2028, with a % CAGR in next six years. The global key manufacturers of Acute Kidney Injury Therapeutics include Quark Pharmaceuticals, Alloksys, Angio Biomedica Corporation, Stealth Bio Therapeutics, Silver Creek Pharmaceuticals, AM Pharma Holding, Ischemix, Biomerieux and A1M Pharma. etc. In 2021, the global top five players have a share approximately % in terms of revenue. We surveyed the Acute Kidney Injury Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment: Global Acute Kidney Injury Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions) Global Acute Kidney Injury Therapeutics Market Segment Percentages, by Type, 2021 (%) Non-drug Drugs Global Acute Kidney Injury Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions) Global Acute Kidney Injury Therapeutics Market Segment Percentages, by Application, 2021 (%) Hospitals Clinic Other Global Acute Kidney Injury Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) Global Acute Kidney Injury Therapeutics Market Segment Percentages, By Region and Country, 2021 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Competitor Analysis The report also provides analysis of leading market participants including: Key companies Acute Kidney Injury Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions) Key companies Acute Kidney Injury Therapeutics revenues share in global market, 2021 (%) Further, the report presents profiles of competitors in the market, key players include: Quark Pharmaceuticals Alloksys Angio Biomedica Corporation Stealth Bio Therapeutics Silver Creek Pharmaceuticals AM Pharma Holding Ischemix Biomerieux A1M Pharma